HACKENSACK MERIDIAN HEALTH
- Country
- πΊπΈUnited States
- Ownership
- -
- Established
- 2016-01-01
- Employees
- -
- Market Cap
- -
Post-Acute Sequelae of Coronavirus-19 (COVID-19) With Dyspnea on Exertion And Associated TaChycardia TrEatment Study
- First Posted Date
- 2021-10-27
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 14
- Registration Number
- NCT05096884
- Locations
- πΊπΈ
Hackensack Univeristy Medical Center, Hackensack, New Jersey, United States
Sinusoidal Galvanic Vestibular Stimulation for Neurogenic Orthostatic Hypotension / Syncope
- Conditions
- Interventions
- First Posted Date
- 2021-07-26
- Last Posted Date
- 2022-12-16
- Lead Sponsor
- Hackensack Meridian Health
- Registration Number
- NCT04976101
- Locations
- πΊπΈ
Hackensack Univeristy Medical Center, Hackensack, New Jersey, United States
Pain Control Without Opioids
- Conditions
- Interventions
- First Posted Date
- 2021-03-24
- Last Posted Date
- 2022-09-10
- Lead Sponsor
- Hackensack Meridian Health
- Registration Number
- NCT04813991
- Locations
- πΊπΈ
Hackensack University Medical Center, Hackensack, New Jersey, United States
ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes
- Conditions
- First Posted Date
- 2021-03-12
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 100
- Registration Number
- NCT04794686
- Locations
- πΊπΈ
Hackensack University Medical Center, Hackensack, New Jersey, United States
The Effectiveness of Osteopathic Manipulative Medicine in the Management of Headaches Associated With Post Concussion Syndrome
- Conditions
- Interventions
- First Posted Date
- 2021-02-01
- Last Posted Date
- 2021-05-25
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 26
- Registration Number
- NCT04732338
- Locations
- πΊπΈ
Hackensack Meridian Health - JFK Medical Center, Edison, New Jersey, United States
A Study of Daratumumab With Pomalidomide, Dexamethasone, and All-Transretinoic Acid in Patients With Multiple Myeloma
- Conditions
- Interventions
- First Posted Date
- 2021-01-07
- Last Posted Date
- 2024-01-10
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 1
- Registration Number
- NCT04700176
- Locations
- πΊπΈ
John Theurer Cancer Center, Hackensack, New Jersey, United States
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
- Conditions
- Interventions
- First Posted Date
- 2020-12-10
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 96
- Registration Number
- NCT04661137
- Locations
- πΊπΈ
John Theurer Cancer Center, Hackensack, New Jersey, United States
πΊπΈLombardi Comprehensive Cancer Center, Washington, District of Columbia, United States
Variability in Transcranial Doppler Technique in Neuro-Critical Care Patients
- First Posted Date
- 2020-10-12
- Last Posted Date
- 2021-11-09
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 12
- Registration Number
- NCT04583163
- Locations
- πΊπΈ
Hackensack University Medical Center, Hackensack, New Jersey, United States
Expanded Access to Convalescent Plasma for Treatment of COVID-19
- Conditions
- First Posted Date
- 2020-07-15
- Last Posted Date
- 2022-10-12
- Lead Sponsor
- Hackensack Meridian Health
- Registration Number
- NCT04472572
- Locations
- πΊπΈ
Hackensack University Medical Center, Hackensack, New Jersey, United States
Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection
- Conditions
- Interventions
- First Posted Date
- 2020-07-02
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 21
- Registration Number
- NCT04456413
- Locations
- πΊπΈ
Hackensack University Medical Center, Hackensack, New Jersey, United States